Significant clinical worsening after natalizumab withdrawal: Predictive factors
Significant clinical worsening after natalizumab withdrawal: Predictive factors
About this item
Full title
Author / Creator
Vidal-Jordana, A , Tintoré, M , Tur, C , Pérez-Miralles, F , Auger, C , Río, J , Nos, C , Arrambide, G , Comabella, M , Galán, I , Castilló, J , Sastre-Garriga, J , Rovira, A and Montalban, X
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
We aimed to single out multiple sclerosis (MS) cases with poor outcome after natalizumab withdrawal and to identify predictive variables. We ascertained 47 withdrawals, and compared their pre- and post-natalizumab periods. We objectively defined significant clinical worsening after natalizumab withdrawal as a 2-step increase in Expanded Disability...
Alternative Titles
Full title
Significant clinical worsening after natalizumab withdrawal: Predictive factors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1808666301
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808666301
Other Identifiers
ISSN
1352-4585
E-ISSN
1477-0970
DOI
10.1177/1352458514549401
